Tuagon, Mark Jade P.
HRN: 19-96-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
01/20/2023
01/24/2023
PO
2.7ml
OD
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes